Reimbursement Series: The ABC & D’s of reimbursement – Part D
Despite the fact that the pharmacy retains the very significant financial responsibility for drug spend and concentrates on trying to limit this in a number of ways, in comparison, pharmacy spends very little time or effort or has very little involvement in ensuring payment for those very expensive high investment drugs or even in designing and implementing payment strategy. The CDM is at the core of this, but unfortunately, often is bloated, cumbersome, outdated and missing critical elements. Additionally, the session provides suggestions and tools for assessing current practice and making needed changes. It’s not only about money but about assuring data accuracy. The series will cover the entire reimbursement cycle including inpatient as well as retail and outpatient reimbursement rules and best practices.
This activity is intended for pharmacists and pharmacy technicians.
At the completion of this activity pharmacists should be able to:
- Provide a basis for staff, new practitioners and clinicians to understand payment aspects of healthcare, a topic not often covered during their formative training
- Identify drug payment/site of care requirements, where the information comes from and who’s responsible in a cross functional multidisciplinary approach to revenue cycle management
At the completion of this activity pharmacy technicians should be able to:
- Identify what’s needed to get paid for a drug in 2022, where the information comes from and who’s responsible.
Absence of Relevant Financial Relationships
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Brian Hardy, MBA, RPh
AVP, Pharmacy Consulting
Jackie Stokes, BS
Manager, Pharmacy Program
Gretchen Brummel, PharmD, BCPS
Consulting Solutions Director
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-22-021-L03-P
Universal Activity Number: JA0006103-0000-22-021-L03-T
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician